Stephen G. Sudovar elected to Aastrom Biosciences' board of directors
Aastrom Biosciences, Inc. announced that Stephen G. Sudovar, former President and CEO of EluSys Therapeutics, Inc. and former President of Roche Laboratories, Inc., has been elected to the Company's Board of Directors effective July 29, 2005.
Mr. Sudovar most recently served as President and CEO of EluSys Therapeutics, Inc., a start-up biopharmaceutical company with a pipeline of products in various stages of development. Prior to joining EluSys in 1999, Mr. Sudovar was the President of Roche Laboratories, Inc., a division of Hoffmann La Roche, Inc. While in this position, the company's revenues tripled over a 10-year period, while consistently increasing divisional profit contribution and substantially increasing the company's share of the U.S. market. Before he assumed the duties of President at Roche, Mr. Sudovar held the positions of Senior Vice President, Executive Director of Special Projects at Basel Headquarters (Switzerland), and Vice President and General Manager.
Prior to joining Roche, Mr. Sudovar was the President, CEO and Chairman of Pracon Incorporated, a health care consulting and communications firm he founded and presided over during ten years of profitable growth. Mr. Sudovar holds a B.S. in Marketing and Finance from St. Peter's College, and an M.B.A. from Fairleigh Dickinson University. He is a member of numerous professional organizations, and has published articles on a wide variety of issues related to the field of health care.
Other news from the department people
